Bone diseases, such as bone defects, cartilage damage, osteomyelitis, and osteoporosis,
are a primary focus area in current research. Cellulose and its derivatives, the most …

Osteoporosis is a common disease that affects millions of patients worldwide and is most
common in menopausal women. The main characteristics of osteoporosis are low bone …

EuOCP3, with a molecular weight of 38.1 kDa, is an acidic polysaccharide purified from
Eucommia ulmoides Oliver cortex. Herein, we determined that the main backbone of …

Nanotechnology changed the concept of treatment for a variety of diseases, producing a
huge impact regarding drug and gene delivery. Among the different targeted diseases …

Osteoporosis (OP) is a chronic bone disease characterized by aberrant microstructure and
macrostructure of bone, leading to reduced bone mass and increased risk of fragile …

Osteoporosis (OP) is one of the most common diseases in the elderly, and it is not effectively
solved by current treatments. Mesenchymal stem cells (MSCs) have multiple differentiation …

Osteoporosis is a systemic skeletal disease characterized by low bone mass and
microarchitectural deterioration of bone tissue, with a consequent increase in bone fragility …

Animal models are fundamental to advance our knowledge of the underlying
pathophysiology of bone loss and to study pharmaceutical countermeasures against it. The …

The onset of osteoporosis leads to a gradual decrease in bone density due to an imbalance
between bone formation and resorption. To achieve optimal drug efficacy with minimal side …

Osteoporosis is a systemic multifactorial bone disease characterized by low bone quality
and density and bone microstructure damage, increasing bone fragility and fracture …